Middle East and Africa In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 Middle East and Africa In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Middle East and Africa In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research In Vitro Diagnostic Devices Research MEA In-Vitro Diagnosis & Treatment Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Middle East and Africa In-Vitro Diagnostics Industry

The Middle East and Africa In-Vitro Diagnostics market is competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market in the GCC. Some of the major players in the market are Abbott Laboratories, BioMerieux SA, Sysmex Corporation, F. Hoffmann-La Roche AG, and Becton, Dickinson, and Company, among others. The companies mostly monitor distribution via their branch offices or distributors operating at the domestic and international levels.

Middle East and Africa In-Vitro Diagnosis & Treatment Market Leaders

  1. Abbott Laboratories

  2. F. Hoffmann-La Roche AG

  3. Becton, Dickinson and Company

  4. Sysmex Corporation

  5. BioMerieux SA

*Disclaimer: Major Players sorted in no particular order

Middle East and Africa In-Vitro Diagnostics Market Concentration

Middle East and Africa In-Vitro Diagnosis & Treatment Market Report Snapshots

Middle East and Africa In-Vitro Diagnosis & Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)